Seyedeh Sindokht Hosseini

Seyedeh Sindokht Hosseini

Auto-generated profile, based on publicly available information

Seyedeh Sindokht Hosseini

Student Research Committee, Birjand University of Medical Sciences , Birjand , Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Dermatology Research and Practice
Verified
Journal Article
Open access
SKSomaye Karimi
Somaye Karimi
NFNarges Fallahi
Narges Fallahi
SHSeyedeh Sindokht Hosseini
Seyedeh Sindokht Hosseini
MFMohammad Fereidouni
Mohammad Fereidouni
FGFahime Ghasemi
Fahime Ghasemi
MRMitra Rafiee
Mitra Rafiee
Introduction: Psoriasis, as a common inflammatory skin disease, is characterized by hyperproliferation of epidermal keratinocytes and induction of an inflammatory response. Apoptosis induction and prevention of the proliferation of keratinocytes can help to treat and manage this disease. Thymoquinone (TQ), a bioactive compound with antioxidant and anti‐inflammatory properties, has also been reported as a natural antitumor agent. This study aimed to evaluate the effects of TQ on proliferation and apoptosis in human keratinocyte cells (HaCaT). Methods: HaCaT cells were treated with increasing concentrations of TQ (1, 2, 4, 6, 8, 16, 32, and 64 μg/mL), and cell viability was assessed using the MTT assay. Apoptosis was analyzed via flow cytometry using Annexin V‐FITC/PI staining. Expression levels of p53, Bax, and BCL‐xl genes were measured by real‐time PCR. Results: TQ significantly reduced cell viability in a dose‐dependent manner, with an IC50 of 11.64 μg/mL after 72 h. Flow cytometry revealed a marked increase in early apoptotic cells following treatment with 8 μg/mL TQ (41.00% ± 5.04%) compared to control (17.8% ± 2.26%, P ≤ 0.001). Gene expression analysis showed significant upregulation of p53, while Bax and BCL‐xl levels showed no significant changes. Conclusion: TQ induces apoptosis in human HaCaT cells primarily through p53‐dependent pathways, suggesting its potential as a therapeutic agent for skin‐related disorders .

19 August 2026 in Hormone Molecular Biology and Clinical Investigation
Verified
Journal Article
Open access
SHSeyedeh Sindokht Hosseini
Seyedeh Sindokht Hosseini
EAElham Akbari
Elham Akbari
SKSomaye Karimi
Somaye Karimi
MFMohammad Fereidouni
Mohammad Fereidouni
GAGholamreza Anani-Sarab
Gholamreza Anani-Sarab
MRMitra Rafiee
Mitra Rafiee
Objectives: Hyperplastic skin disorders such as psoriasis are characterized by excessive keratinocyte proliferation, impaired apoptosis, oxidative stress, and sustained activation of innate immune pathways. While conventional treatment primarily targets these mechanisms, emerging interest focuses on the immunomodulatory roles of sex hormones such as progesterone (P4). Clinical observations that psoriasis symptoms often improve during pregnancy, when P4 levels increase, further support this hypothesis. However, the direct effects of P4 on keratinocyte behavior and related molecular pathways remain poorly understood. The study aimed to evaluate the impact of P4 on key pathological features of keratinocytes using the HaCaT cell line as an in vitro model. Methods: HaCaT cells were cultured in DMEM medium with 10 % FBS and 1 % penicillin/streptomycin. Cells treated with various concentrations of P4, as well as untreated controls, were incubated at 37 °C incubator with 5 % CO 2 for 1–3 days. Following treatment, cell viability, apoptosis, oxidative stress, and Toll-like receptor 2 (TLR2) expression were assessed using MTT assay and flow cytometry. Results: P4 significantly reduces keratinocyte proliferation and promotes apoptosis. Moreover, it also decreased intracellular reactive oxygen species (ROS) levels and downregulated TLR2 surface expression (p value≤0.05). Conclusions: These findings highlight the multifaceted ability of P4 to modulate keratinocyte biology by regulating proliferation, apoptosis, oxidative balance, and inflammatory signaling. Interestingly, these effects occurred despite the absence of specific membrane P4 receptors, suggesting alternative pathways may mediate its actions. Further investigations under inflammatory conditions and in vivo models are warranted to validate these results and explore potential therapeutic applications.